Pacific Biosciences of California Inc

Financials

Activos totales 413.98 M2.01 B1.77 B1.75 B1.26 B784.08 M Total de pasivos 78.49 M1.22 B1.2 B1.04 B753.85 M778.73 M Capital total 335.49 M790.99 M562.9 M701.3 M506.59 M5.35 M Total de pasivos y patrimonio neto 413.98 M2.01 B1.77 B1.75 B1.26 B784.08 M Deuda total —3.9 M4.14 M892.73 M647.49 M645.38 M Deuda neta —-90.65 M174.32 M-589.72 M282.5 M422.92 M

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

PACB

Financials

Pacific Biosciences of California Inc

Noticias

MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes

Stryker to Acquire AVS, Adding IVL Capabilities to Vascular Portfolio

RVTY Unveils Signals BioDesign for Faster Molecular Cloning & R&D Data

Three Best Genomics Stocks for Your Portfolio in 2026

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study

GEHC Unifies bkActiv With Stealth AXiS for Live Neurosurgery Imaging

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension

Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now

GRAIL Partners With Epic to Broaden Galleri Test Access Across US

Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now

Artivion Secures FDA Approval for NEXUS Aortic Arch System